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Abstract
Background: Complex interventions to improve compliance to pharmacological treatment in older people have
given mixed results and are not easily applicable in clinical practice. The aim of this study was to test the short-
term efficacy on self-reported medication adherence of an easy intervention in which the patient or caregiver was
asked to transcribe the pharmacological treatment while it was dictated to him/her by the doctor.
Methods: Pilot non-randomised controlled trial involving 108 community-dwelling outpatients aged 65+ (54 in the
intervention arm, 54 controls) referred to a geriatric service from May to July 2009 and prescribed by the
geriatrician a change in therapy. The intervention was applied at the end of the visit to the person managing the
medications, be it the elder or his/her caregiver. Outcome of the study was the occurrence of any adherence error,
assessed at a one-month follow-up by means of a semi-structured interview.
Results: The socio-demographic, functional and clinical characteristics of the two compared groups were similar at
baseline. At a one-month follow-up 43 subjects (40%) had made at least one adherence error, whether
unintentional or intentional. In the intervention group the prevalence of adherence errors was lower than in
controls (20% vs 59%; adjusted odds ratio 0.16, 95% confidence interval 0.07 - 0.39; p < 0.001) after adjusting for
the person managing the medications, the adherence errors at baseline and for the number of prescribed drugs.
Conclusions: In an older outpatient population the intervention considered was effective in reducing the
prevalence of adherence errors in the month following the visit.
Trial registration: Australian and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000347965
Background
About 20% of community-dwelling adults aged 65 and
older take 10 or more medications daily and polyphar-
macy in general has been associated with a higher risk of
non-adherence to treatment [1,2]. Adherence to treat-
ment can be defined as the extent to which a patient’s
actual drug regimen - in terms of dosage, time and mode
of administration of the drugs - corresponds to the pre-
scriptions made by the doctor [3]. In older people a poor
adherence to pharmacological treatment has been
reported in 26 - 59% of cases, depending on the popula-
tion considered and on the operational definition of
adherence adopted in different clinical trials [4-9], and is
associated with a decline in clinical status, a greater risk
of falls, hospitalisation and death as well as an increase in
health expenditures [4,10].
The main barriers to adherence in elders are forgetting
to take the drug, limited organisational skills, belief that
the drug is ineffective or unnecessary, and costs [1]. With
reference to organisational skills, a study involving an
elderly population has highlighted that about 22% of
those who had physical disabilities and about one third of
those affected by cognitive impairment actually managed
their own medications [11]. Another study has found
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that about half of the elders had difficulties in under-
standing the instructions concerning drug therapy [12].
Adherence can be improved by providing caregivers to
elders who are unable to take their medications properly
and by encouraging doctors to routinely review their
patients’ pharmacological treatment in order to ensure
that drug regimens are adequate and as simple as possi-
ble [1,2,13]. Moreover, there is evidence that a better
adherence can be obtained if patients (and caregivers) are
engaged in decisions about starting or keeping or chan-
ging a chronic therapy [9]; in the specific case of frail
older patients it has been shown that their desire for
involvement is essentially fulfilled by good communica-
tion and information and does not extend to the deci-
sion-making process [14].
Nevertheless, according to recent reviews, clinical trials
to determine the efficacy of a range of different interven-
tions on the adherence to treatment of older subjects
seem to offer a rather bleak outlook: results are mixed
and the average increase in adherence in the intervention
group compared to the control group is low (11%)
[13,15-18]. It must however be emphasised that these
clinical trials have a number of limitations: the interven-
tions tested are complex and expensive and therefore
difficult to apply to everyday clinical practice; almost all
interventions combine more than one strategy and it is
not possible to evaluate the effects on adherence of their
individual components; there is often little involvement
of the patient who is thus confined to a mainly passive
role; adherence to treatment is high even in the control
groups, probably because patients derive motivation from
the mere awareness they are participating in a research
study on adherence; baseline adherence is already high
because patients affected by cognitive impairment, at risk
of non-adherence, are often excluded [15-18].
We hypothesize that a simple intervention at the end of
the visit - i.e. the transcription by the patient or caregiver
of the pharmacological treatment dictated to him/her by
the doctor - can be valuable in improving patients’ adher-
ence to therapy, at least in the short term. Such interven-
tion has the potential to be effective both psychologically
and organisationally. Psychologically because it can
enhance the sense of empowerment of patients/care-
givers by allowing them to play a more active role in the
health-care process. Organisationally because it results in
a medication schedule in which the dosages and the
times of administration of the prescribed drugs have
been clearly noted under the doctor’s supervision: this
can avoid the mistakes that occur when, on their own,
the patients or caregivers copy the pharmacological treat-
ment from the medical report into an informal scheme
for personal use and can also offer the doctor a further
opportunity to dissipate misunderstandings and even-
tually tailor the treatment to the patients’ daily routine.
Aim of the study was therefore to assess the short-
term (i.e. one month) efficacy of an intervention of this
kind on the self-reported adherence to pharmacological
treatment in a sample of older community-dwelling sub-
jects referred to an outpatient geriatric service in Milan,
Italy.
Methods
Design, setting and participants
This pilot non-randomised controlled, parallel trial consid-
ered for inclusion a sample of 151 older people (i.e. aged
65+) consecutively referred to the outpatient geriatric
service of the Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico in Milan, Italy, from May 2nd to July
31st 2009. Patients were referred by their general practi-
tioners (GPs) in order to receive a comprehensive geriatric
assessment and medical advice for several reasons includ-
ing functional decline, falls, weight loss, cognitive decline,
depression, and management of multi-drug therapy.
Patients were selected at the end of their visits according
to the following inclusion criteria: living in the community,
taking at least one drug a day, having been prescribed a
change in pharmacological treatment during the visit (i.e.
at least one drug was added or suspended by the doctor)
and - in the case of patients dependent in the management
of medications - having with them at the visit the caregiver
who was in charge of the administration of drugs. Accord-
ing to these inclusion criteria 120 subjects were enrolled
in the study (Figure 1). The study protocol was designed
and performed according to the code of ethics of the
Declaration of Helsinki. All patients and caregivers (if
included, see next paragraph) gave written informed con-
sent to participation in the study.
Baseline comprehensive geriatric assessment
All patients during their visits underwent a comprehensive
geriatric evaluation, performed by a multi-professional
team including two geriatricians, from which baseline mea-
sures were retrieved. The main socio-demographic charac-
teristics of the older participants (age, gender, years of
schooling and living arrangements) were considered and
detailed information on medical history was also collected.
Functional status was assessed by means of the Basic Activ-
ities of Daily Living (BADL) [19] and Instrumental Activ-
ities of Daily Living (IADL) [20] scales, cognitive status by
means of the Mini-Mental State Examination (MMSE)
scale with score correction for age and education [21],
emotional status by means of the 5-item Geriatric Depres-
sion Scale (GDS) [22] in subjects without dementia and the
Cornell scale for depression in dementia in the remaining
subjects [23], comorbidity by means of the Cumulative Ill-
ness Rating Scale morbidity (CIRS-m) and severity (CIRS-
s) scales [24], nutritional status by means of the Mini
Nutritional Assessment Short Form (MNA-SF) [25].
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The caregiver, either informal or formal, was also
recruited if he/she was responsible for the provision of
drug therapy. We considered the following characteris-
tics of caregivers: age, years of schooling and levels of
distress quantified by means of the Caregiver Burden
Inventory scale (CBI) [26]. With regard to the pharma-
cological treatment prescribed during the visit we con-
sidered different variables: the number of specific drugs
to be taken daily, the number of overall drug adminis-
trations per day and the classes of drugs involved.
At the baseline visit the two geriatricians involved in
the CGA asked the patients and/or their caregivers if
they were willing to give their consent to answering a
brief semi-structured interview on the adherence to phar-
macological treatment in the preceding month. The
semi-structured interview was administered to the person
who managed the medications and inquired about possi-
ble adherence errors, classified as ‘unintentional’ or
‘intentional’. The former are not deliberate, i.e. they are
made by subjects who wish to follow the doctor’s pre-
scriptions but are for some reason unable to do so prop-
erly; they can, for instance, be ascribed to forgetfulness,
misunderstanding or temporary lack of access to the
drug (running out of medication supplies or not being at
home at the time the drug should be taken). The latter
are deliberate, i.e. they are made by subjects who inten-
tionally decide not to follow the prescribed regimen due
to misconceptions about illness and medication; they
derive from personal beliefs regarding the need, effective-
ness and safety of drugs and include not taking a
151
Subjects consecutively referred 
to the outpatient service
120
Subjects enrolled at baseline
31 Excluded cases:
3 living in a nursing home facility
5 not taking any drug
14 not being prescribed a change in therapy
9 cognitive impairment, no caregiver at the visit 
60
Assigned to intervention
60
Assigned to control
54
Included in analysis 
at follow-up
54
Included in analysis 
at follow-up
6 Missing cases:
2 not reached on the phone 
4 lacked informed consent
6 Missing cases:
2 not reached on the phone 
4 lacked informed consent
Figure 1 Study participants, their allocation and follow-up.
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prescribed drug (never starting the treatment or stopping
it) or, conversely, not suspending a drug deemed inap-
propriate or potentially harmful by the doctor. During
the interview participants (patients or caregivers) were
asked to focus on the month prior to the visit and indi-
cate for each of the drugs listed in the referral letter from
their GP if i) it had been taken/given correctly in terms
of dosages and times of administration, ii) it had not
been taken/given correctly because of forgetfulness, mis-
understanding or temporary unavailability, iii) it had not
been taken/given correctly because of a deliberate choice
to never take it/give it or to suspend it. Moreover,
patients/caregivers were asked if they were taking/giving
drugs not prescribed by the doctor or that the doctor had
decided to suspend. Since subjects are often reluctant to
admit to non-adherence [9], possible errors were investi-
gated in a tactful and neutral manner so that patients/
caregivers would not feel their conduct was being judged
(e.g. ‘We know it is hard to take all these medicines regu-
larly, if you look back at the last month has it ever hap-
pened that you missed a dose of a drug ?’; ‘In the last
month did you make any adjustment to the drug regimen
prescribed by the doctor because you felt uncomfortable
with it?’).
Intervention
The two geriatricians involved in the baseline visit were
blinded to the allocation of participants. At the end of
the visit, a third geriatrician - who had ready access to
the information noted by his colleagues in the medical
record - selected participants according to the inclusion
criteria, alternately allocated them to the intervention or
control groups (allocation ratio 1:1) and administered the
intervention after having described it to the participants
and having obtained a written consent to it. Thus at the
end of the visit half of the subjects (n = 60) fulfilling
inclusion criteria underwent a quick and easy interven-
tion with the objective to improve their adherence to
pharmacological treatment. It was applied to the person
managing the medications (patient or caregiver) who was
asked to write down on a sheet of paper the drug regi-
men that had been prescribed (i.e. all prescribed medica-
tions and not only new/changed medications). This was
dictated to him/her by the doctor to obtain a schedule of
pharmacological treatment in which the times of admin-
istration of the drugs were noted along with their
dosages. The doctor supervised the operation, making
sure that the transcription was correct and clear, and the
patient or caregiver was then given the schedule for use
at home. The other half of the study population received
no such intervention but only the standard procedure
available at our outpatient geriatric service: the pre-
scribed pharmacological treatment was stated at the end
of the medical report and reviewed orally by the
geriatrician performing the visit with the person in
charge of medications. The patient or caregiver was then
given a copy of the medical report containing the medi-
cation instructions. All the doctors taking part in the
study were adequately trained so as to ensure they
offered patients an approach that would be as much as
possible uniform. In particular they were instructed on
how to carefully collect information on pharmacological
treatment at baseline, how to tactfully inquire about pos-
sible adherence errors in the month prior to the visit,
how to orally review the prescribed therapy in an accu-
rate manner and - for the intervention group - how to
involve patients/caregivers in the dictation procedure. In
order to verify the consistency of the doctors’ behaviour
and to estimate the duration of the intervention, for the
first 40 cases recruited (20 in the intervention arm, 20
controls) an independent medical investigator was also
present at the visit and during the intervention - when
this was performed - to function as a supervisor.
One-month follow-up
One month after the visit the person managing the medi-
cations (patient or caregiver) was called on the phone by
another investigator, who had not been involved in the
preceding steps and was therefore blinded to baseline
adherence and group assignment, in order to assess the
adherence to the pharmacological treatment prescribed
at the visit (i.e. written by the doctor in the medical
report of the visit). Outcome of the study was taken to be
the presence of at least one self-reported adherence error
of any kind (i.e. unintentional or intentional) during this
period. Errors were evaluated by means of the same
semi-structured interview used at baseline (see Baseline
comprehensive geriatric assessment). One month was
considered an appropriate time interval for a short-term
follow-up, in accordance with the inclusion criteria of a
recent review of randomised clinical trials aimed at
improving medication adherence in community-dwelling
elders [15]. In order to avoid a potential bias (i.e. an arti-
ficially low prevalence of adherence errors in both
groups) participants were not told in advance they would
be given a subsequent telephone interview to evaluate
their adherence to treatment; it is a standard procedure
of the visits at our outpatient geriatric service to ask
patients and/or caregivers if they consent to leaving tele-
phone numbers at which they can be reached if neces-
sary. All the participants who were contacted on the
phone after one month were mailed an informed consent
form for the treatment of the personal data obtained at
follow-up and were invited to fill it in and send it back to
us. Unfortunately, 12 patients were lost to follow-up: four
(two in each group) could not be contacted on the phone
and eight (four in each group) of those who were con-
tacted lacked informed consent. The study sample was
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therefore composed of 108 patients (Figure 1). The
demographic characteristics of the 12 patients lost to fol-
low-up were consistent with those of the recruited
sample.
Statistical analyses and sample size calculations
The main baseline characteristics of the sample were
analysed by calculating means and standard deviations
for metric variables and percentages for nominal vari-
ables. The comparison between the two groups - inter-
vention group and control group - was carried out using
Student’s t-test for metric variables with a normal distri-
bution and the chi-squared test or Fisher’s exact test for
nominal variables. In order to assess the efficacy of the
intervention after one month, a multivariate logistic
regression analysis was conducted with the study out-
come (see previous section) as the dependent variable
and having received the intervention as the covariate;
corrections were made for adherence errors at the base-
line evaluation, number of prescribed drugs (i.e. highest
tertile vs rest) and for the person who managed the medi-
cations (i.e. patient or caregiver). A p value < 0,05 was
assumed to indicate statistical significance. Statistical
analyses were performed by means of the statistical pack-
age SPSS 14.0 for Windows.
As far as the sample size was concerned, since ours was
meant to be a pilot study and loss to follow-up was
assumed to be negligible because of the short duration of
the follow-up (one month), we recruited 120 subjects at
the baseline evaluation in order to have 60 subjects in
each group. Even though a few participants were actually
lost at follow-up, it was calculated that a sample of 54
cases per group had a statistical power of 80% at a 5%
alpha level to detect an absolute decrease of 23% of non-
adherence to medication in the intervention group, assum-
ing nearly 50% of non-adherence in the control group [8].
Results
Baseline evaluation: characteristics of the sample
The sample was composed of 108 subjects with a mean
age of 80 (range 65-95), 66% (n = 71) of whom were
women. Thirty-seven percent (n = 40) of patients were
affected by cognitive impairment and 67% (n = 72) suf-
fered from symptoms of depression. Forty-nine partici-
pants (45%) had more than five chronic diseases, i.e. a
comorbidity index greater than 5 at the CIRS. With regard
to the pharmacological treatment prescribed at the visit,
patients had to take an average of 5.5 (SD 2.6) drugs per
day and the mean number of daily drug administrations
was 6.5 (SD 3.3). The most commonly prescribed drugs
were: antiaggregants/anticoagulants (69%), antihyperten-
sives (69%), gastroprotectives (44%) and antidepressants
(42%). In 40% of cases (n = 43) it was the caregiver who
managed the medications.
In 69% (n = 74) of the sample we observed at least
one adherence error of any kind in the month prior to
the visit: 28% (n = 30) of the participants made only
unintentional adherence errors, 24% (n = 26) made only
intentional adherence errors, while 17% (n = 18) made
both types of errors.
The baseline profile of the 108 patients belonging to the
intervention and control groups is summarised in Table 1:
the two groups were similar in terms of socio-demographic
data, functional status, comorbidity, polipharmacy and pre-
valence of non-adherence errors in the past month as well
as characteristics of the caregivers (when present). The
median duration of the intervention, assessed for the first
20 cases assigned to the intervention group, was 3 minutes
(range 1 to 5 minutes).
One-month follow-up
At the follow-up, carried out one month after the visit,
we found that 43 subjects (40%) had made at least one
adherence error, whether unintentional or intentional, in
this interval of time. The prevalence of adherence errors
was 20% (n = 11) in the intervention group and 59% (n =
32) in the control group (p < 0.001) (Table 2). At multi-
variate logistic regression analysis the intervention tested
was associated with a lower risk of making errors of any
kind in the adherence to pharmacological treatment
when compared to the control group (odds ratio 0.16,
95% confidence interval 0.06 - 0.39; p < 0.001), after
adjusting for previous adherence errors (i.e. prevalence of
adherence errors at the baseline evaluation) and for the
person who was in charge of the medications (i.e. patient
or caregiver) (Table 3 model a). The results of the multi-
variate analysis were unchanged even after adjusting for a
large number of drugs taken (Table 3 model b).
Discussion
The intervention assessed in our study - i.e. the transcrip-
tion by the patient/caregiver of the pharmacological
treatment dictated to him/her by the doctor at the end of
the visit - was found to be effective since there was a sig-
nificantly lower prevalence of adherence errors in the
intervention group (20%) than in the control group (59%)
in the month following the visit. The improvement in
adherence was confirmed after adjusting for the adher-
ence at baseline, the number of prescribed drugs and the
person to whom the intervention was directed (patient or
caregiver, according to who managed the medications).
The relevance of these findings is enhanced by the fact
that the intervention was demonstrated to be effective in
a population at high risk of non-adherence - older sub-
jects who had been prescribed a change in their usual
pharmacological treatment and who had to take an aver-
age of five drugs per day - and that it was tested against a
control group who underwent a standard procedure
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which is itself very much focused on improving adher-
ence. In fact it is part of the geriatrician’s routine practice
to simplify and personalise the drug regimens of the
older patients and to make sure that all instructions are
clear and understood. Indeed even in the control group
the prevalence of adherence errors was slightly reduced -
from 67% to 59% - from baseline to follow-up.
Our study shows a greater increase in adherence from
the intervention to the control group than most studies
on adherence carried out in older populations (please see
Background). This could be because in the intervention
Table 1 Baseline characteristics of the 108 older participants and their 43 caregivers
Variables Intervention
(n = 54)
Control
(n = 54)
P value
Mean (SD) Perc. (n) Mean (SD) Perc. (n)
Older participants
Age, years 79.8 (6.4) 80.6 (7.1) 0.543
Sex: female 63 (34) 69 (37) 0.543
Living alone 50 (27) 44 (24) 0.780
Education, years 8.8 (5) 8.5 (4.4) 0.698
BADL scorea 4.6 (1.6) 4.4 (1.5) 0.623
IADL scoreb 4.6 (2.9) 4.3 (2.7) 0.495
Dependence in taking medications 35 (19) 44 (24) 0.326
CIRS m scorec 4.2 (1.8) 4.1 (1.6) 0.610
CIRS s scored 1.9 (0.5) 1.9 (0.3) 0.543
MMSE scoree 24.1 (6.3) 23.7 (6.3) 0.726
5-item GDS scoref 2.4 (1.3) 2.0 (1.3) 0.162
Cornell scale scoreg 13.4 (5.2) 15.0 (5.1) 0.344
MNA SF scoreh 10.4 (2.1) 9.7 (2.4) 0.132
Drugs daily, n 5.5 (2.6) 5.4 (2.6) 0.854
Drug administrations daily, n 6.7 (3.6) 6.4 (3.1) 0.668
Any adherence errori 70 (38) 67 (36) 0.679
Any intentional adherence error 41 (22) 41 (22) 1.000
Therapy suspended 33 (18) 26 (14) 0.399
Therapy never taken 11 (6) 19 (10) 0.417†
Therapy never stopped 2 (1) 13 (7) 0.060†
Any unintentional adherence error 52 (28) 37 (20) 0.121
Caregivers (n = 19) (n = 24)
Age, years 62.8 (16) 58.1 (18.9) 0.380
Education, years 7.5 (3.3) 7.6 (3.8) 0.955
CBI scorel 35.2 (22.1) 37.1 (20.9) 0.766
† Statistical analysis was performed by using Fisher’s exact test.
a BADL = Basic Activities of Daily Living; normal score 6/6. Lower scores indicate worse functional status.
b IADL = Instrumental Acitivities of Daily Living; normal score 8/8. Lower scores indicate worse functional status.
c CIRS m = Cumulative Illness Rating Scale morbidity. Score range 0-13; lower scores indicate lower morbidity.
d CIRS s = Cumulative Illness Rating Scale severity. Score range 1-5; lower scores indicate less severe multiple pathology.
e MMSE = Mini Mental State Examination. Score range 0-30. Scores are corrected for age and education. Lower scores indicate worse cognitive function.
f GDS = Geriatric Depression Scale. Score range 0-5. Higher scores indicate worse emotional status. This variable was analysed only in the 68 participants (34 per
group) without cognitive impairment.
g Score range 0-38, higher scores indicate worse emotional status. This variable was analysed only in the 40 participants (20 per group) suffering from cognitive
impairment (i.e. MMSE score < 24 out of 30 after correction for age and education).
h MNA SF = Mini Nutritional Assessment Short Form. Score range 0-14. Lower scores indicate higher risk of malnutrition.
i The sum of any intentional and any unintentional errors is over 100% because we found both kinds of errors in 18 cases: 12 cases belonging to the
intervention group and 6 cases belonging to the control group.
l CBI = Caregiver Burden Inventory. Score range 0-96, higher scores indicate greater distress of the caregiver.
Table 2 Non-adherence to medications at a one-month
follow-up
Outcomes Intervention
(n = 54)
Control
(n = 54)
P value
Perc. (n) Perc. (n)
Any adherence error 20 (11) 59 (32) < 0.001
Therapy suspended 13 (7) 33 (18) 0.021†
Therapy never taken 7 (4) 28 (15) 0.010†
Therapy never stopped 0 (0) 19 (10) 0.001†
Unintentional adherence error 15 (8) 32 (17) 0.067†
† Statistical analysis was performed by using Fisher’s exact test.
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we tested, unlike in others, the patient/caregiver who
manages the medications is not just a passive recipient of
information but is made to play a more active role in the
partnership with the physician, thus enhancing his/her
motivation. It is acknowledged that adherence to therapy
is also a matter of personal choice [16]. Moreover, the
transcription of therapy engages two sensory channels
(i.e. listening and writing) while the standard procedure
only one (i.e. listening) and this could favour the learning
process. In addition, a medication schedule in which the
dosages and the times of administration of the drugs are
written under the doctor’s supervision can hold several
advantages: prevention of transcription errors and the
opportunity to clear misunderstandings and tailor the
treatment to the patient’s daily routine.
Another point deserving further discussion is that the
prevalence of adherence errors observed in the control
group after the visit is relatively higher than is reported
in literature [4-9], notwithstanding the short duration of
our follow-up (one month). A possible explanation lies in
the selection of a sample at high risk of non-adherence
(the patients considered were those who had been pre-
scribed a change in the pharmacological treatment dur-
ing the visit), in having considered both intentional and
unintentional medication errors, and in the avoidance of
a potential bias due to the awareness that adherence
would be subsequently re-evaluated. In fact patients and
caregivers were not told in advance they would be given
a phone interview after one month and this was a metho-
dological choice which distinguishes our study from most
other studies and could constitute one of its strengths.
There are several other strengths to our study: we
analysed adherence to the complex multi-drug regimens
that are the rule in older subjects, while many studies
have considered younger subjects and/or adherence to a
specific class of medications [15,16,27-29]; we tested a
single intervention easy to apply to everyday clinical
practice whereas many studies have tested complex and
combined strategies, often administered by appropriately
trained health-care professionals like nurses and phar-
macists, whose routine application would be more cum-
bersome [16,30-35]; we assessed the efficacy of our
intervention both on patients and on caregivers (when
they were in charge of the medications).
The study also has some limitations. Having been con-
ceived as a pilot study, the main ones are the fact that the
geriatrician who administered the intervention was not
blinded to group assignment, the relatively small sample
size and the short duration of the follow-up period. The
limited sample size did not allow us to separately evaluate
the effect of the intervention on the two types of adher-
ence error (i.e. unintentional or intentional). The short
duration of the follow-up enabled us to assess the efficacy
of the intervention only in the short-term. Furthermore,
this study was not a randomised one according to CON-
SORT guidelines, since participants were alternately allo-
cated to the intervention or control groups. However we
have to underline that the socio-demographic, functional
and clinical characteristics, including the number of pre-
scribed drugs, of the two compared groups were similar
at baseline. Further randomised controlled studies will
therefore be necessary to confirm the efficacy of the
intervention on a larger sample of community-dwelling
older people and to extend the investigation to longer
follow-up periods (mid-term and long-term).
Some mention must also be made of a key methodolo-
gical issue: the outcome of the study (i.e. the occurrence
of any adherence error during a one-month period) was
evaluated by means of a semi-structured phone interview.
Although this approach suffers from the limitations
imposed by self-reporting, such as the recall and social
desirability biases (i.e. not remembering or not admitting
errors) we still believe it is a reasonable choice when
compared to other options like structured interviews (e.g.
the Morisky scale) and Medication Event Monitoring
Systems (MEMSs). The Morisky scale not only exhibits
the same limitations due to self-reporting but also does
not consider, even in its most recent expanded version
[36], some of the intentional errors investigated by our
semi-structured interview, like never starting the treat-
ment or not suspending a drug deemed inappropriate or
potentially harmful by the doctor. MEMSs certainly pro-
vide an objective and reliable measure of adherence but,
since patients are necessarily aware they are being moni-
tored, these devices are known to improve adherence in
the short-term [37,38]; the use of MEMSs would have
thus introduced an important bias in a study focusing on
adherence in the first month after an intervention.
We included in the study subjects who had been pre-
scribed a change in the pharmacological treatment
Table 3 Logistic regression analysis of non-adherence to
medications at follow-up (n = 108)
Variables Adjusted
OR
95% CI P
value
Model a)
Educational intervention 0.16 0.06 - 0.39 < 0.001
Baseline characteristics
Any intentional adherence error 1.62 0.68 - 3.86 0.276
Any unintentional adherence error 1.29 0.53 - 3.15 0.572
Therapy managed by the
caregiver
0.71 0.29 - 1.74 0.452
Model b)†
Educational intervention 0.16 (0.07 -
0.39)
< 0.001
† Model adjusted even for a large number of prescribed drugs (highest tertile
vs rest, i.e. 7+ drugs vs rest) besides the baseline covariates of Model a.
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during the visit (i.e. those at higher risk of non-adher-
ence) and excluded subjects whose drug regimens were
unchanged (i.e. those at lower risk of non-adherence).
This choice was made in order to ensure that the sam-
ple considered would be as homogeneous as possible in
terms of the risk of non-adherence and to test the effi-
cacy of the intervention in the most challenging adher-
ence scenario.
In our study patients unable to take their medications
properly were included only if they had a caregiver who
was responsible for the provision of therapy. A recent
study carried out in Germany has shown that among
older outpatients suffering from Alzheimer’s disease
compliance to antidementia drugs, such as donepezil
and memantine, was relatively high, but drug therapy
was supervised or completely managed by the carers in
94% of participants [39]. Therefore a suggestion for
further research can be addressing the issue of adher-
ence in dependent subjects lacking assistance.
Conclusions
In an older outpatient population referred to our geria-
tric service the transcription by the patient/caregiver of
the pharmacological treatment dictated to him/her by
the doctor at the end of the visit was effective in signifi-
cantly reducing the prevalence of adherence errors in
the month following the visit. The intervention tested in
this study, simple and easy to apply, could be routinely
used in everyday clinical practice to improve medication
adherence, at least in the short-term, among commu-
nity-dwelling elders and their caregivers.
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